Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Vilas Patwardhan, M.D.

Co-Author

This page shows the publications co-authored by Vilas Patwardhan and Alan Bonder.
Connection Strength

2.745
  1. Cholestatic Liver Disease and Pregnancy: A Systematic Review and Meta-Analysis. J Clin Med. 2022 Feb 18; 11(4).
    View in: PubMed
    Score: 0.247
  2. Race/Ethnicity Is Not Independently Associated with Risk of Adverse Waitlist Removal among Patients with HCC Exception Points. J Clin Med. 2021 Dec 13; 10(24).
    View in: PubMed
    Score: 0.244
  3. Waitlist Mortality and Posttransplant Outcomes in African Americans with Autoimmune Liver Diseases. J Transplant. 2021; 2021:6692049.
    View in: PubMed
    Score: 0.238
  4. New OPTN Simultaneous Liver-Kidney Transplant (SLKT) Policy Improves Racial and Ethnic Disparities. J Clin Med. 2020 Dec 01; 9(12).
    View in: PubMed
    Score: 0.227
  5. Thinking Outside of Urso. Clin Liver Dis (Hoboken). 2020 Aug; 16(2):38-42.
    View in: PubMed
    Score: 0.223
  6. Increased Posttransplant Mortality for Autoimmune Hepatitis Compared With Other Autoimmune Liver Diseases. J Clin Gastroenterol. 2020 08; 54(7):648-654.
    View in: PubMed
    Score: 0.222
  7. Treatment of Overlap Syndromes in Autoimmune Liver Disease: A Systematic Review and Meta-Analysis. J Clin Med. 2020 May 13; 9(5).
    View in: PubMed
    Score: 0.218
  8. Mortality on the UNOS Waitlist for Patients with Autoimmune Liver Disease. J Clin Med. 2020 Jan 23; 9(2).
    View in: PubMed
    Score: 0.214
  9. Pharmacologic management of primary sclerosing cholangitis: what's in the pipeline? Expert Rev Gastroenterol Hepatol. 2019 Aug; 13(8):723-729.
    View in: PubMed
    Score: 0.206
  10. Treatment of Fatigue in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis. Dig Dis Sci. 2019 08; 64(8):2338-2350.
    View in: PubMed
    Score: 0.199
  11. Hyperlipidaemia in primary biliary cholangitis: treatment, safety and efficacy. Frontline Gastroenterol. 2019 Oct; 10(4):401-408.
    View in: PubMed
    Score: 0.199
  12. Treatment cessation in noncirrhotic, e-antigen negative chronic hepatitis B is safe and effective following prolonged anti-viral suppression with nucleosides/nucleotides. Aliment Pharmacol Ther. 2014 Oct; 40(7):804-10.
    View in: PubMed
    Score: 0.147
  13. Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation. J Hepatol. 2022 Feb 08.
    View in: PubMed
    Score: 0.062
  14. Altered aryl-hydrocarbon-receptor signalling affects regulatory and effector cell immunity in autoimmune hepatitis. J Hepatol. 2021 01; 74(1):48-57.
    View in: PubMed
    Score: 0.055
  15. Hospital-level balloon tamponade use is associated with increased mortality for all patients presenting with acute variceal haemorrhage. Liver Int. 2018 03; 38(3):477-483.
    View in: PubMed
    Score: 0.045
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.